PYC Therapeutics Ltd
ASX:PYC
PYC Therapeutics Ltd
ASX:PYC
Price:
1.345
AUD
-5.28%
Market Closed
Market Cap:
784.5m
AUD
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
-15.2
Current
-16.8
Median
5.1
Industry
Higher
than median
Lower
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=-15.2
Enterprise Value
/
736.1m AUD
EBITDA
-48.5m AUD
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
-12
2-Years Forward
EV/EBITDA
-10.2
3-Years Forward
EV/EBITDA
-7.3
You don't have any saved screeners yet
